The 'Big Three' Hair Loss Protocol: Finasteride, Minoxidil, and Ketoconazole Explained

"The Big Three" is the shorthand for the evidence-backed combination therapy for androgenetic alopecia: finasteride + minoxidil + ketoconazole. It's the most-studied combination for slowing and reversing pattern hair loss, and each component works through a different mechanism. Here's how they fit together.

01Finasteride: the DHT blocker

Finasteride 1mg daily blocks 5-alpha-reductase type II, reducing scalp DHT by approximately 70%. DHT is the androgen that miniaturizes follicles in genetically susceptible men (and some women). Blocking it slows or stops the miniaturization process. Clinical trials show approximately 90% of men on finasteride for 5 years maintain or improve their hair count, vs significant continued loss in placebo.

Requires a prescription. Available via telehealth in 15 minutes. Generic is around $10–15/month with a GoodRx coupon.

02Minoxidil: the growth promoter

Topical minoxidil (5% foam or liquid) extends the anagen (growth) phase of the hair cycle and promotes follicular vasodilation — better blood supply to the follicle. FDA-approved for both men and women. Available OTC. Takes 3–6 months to show meaningful response. Applied twice daily to the scalp.

The combination with finasteride is additive: finasteride reduces the miniaturization signal; minoxidil promotes active growth. Together they outperform either alone in head-to-head trials.

03Ketoconazole shampoo: the scalp environment

Used 2–3x weekly in place of regular shampoo. Leave it on 2–5 minutes before rinsing. It reduces scalp DHT locally (through weak anti-androgenic activity) and addresses seborrheic dermatitis — a scalp condition driven by Malassezia yeast that accelerates follicle inflammation and worsens AGA. The OTC Paid link Nizoral 1% shampoo is the same ingredient used in the clinical literature.

04What to expect on the combination

• Month 1–3: possible initial increased shedding (minoxidil shedding phase) — expected and temporary
• Month 3–6: shedding resolves, early density changes in some zones
• Month 6–12: visible improvement in most responders
• Month 12+: full assessment; ongoing maintenance phase